VITAMINS
Online ISSN : 2424-080X
Print ISSN : 0006-386X
Volume 92, Issue 2
Displaying 1-20 of 20 articles from this issue
  • Takahisa Ogawa
    2018 Volume 92 Issue 2 Pages 53-62
    Published: February 25, 2018
    Released on J-STAGE: February 28, 2019
    JOURNAL FREE ACCESS
    The Nudix (Nucleoside diphosphate linked to some other moiety X) hydrolases, NUDXs, are the protein family that hydrolyzes a wide variety of nucleoside diphosphate derivatives including canonical and oxidized nucleoside di- and triphosphates, nucleotide-sugars, and several coenzymes such as NAD(P) H, FAD, and CoA which are derived from niacin, Àavin, and pantothenic acid, respectively. Arabidopsis thaliana possesses 28 NUDX genes (AtNUDX1-27 and DCP2) divided into three types, i.e., cytosolic, chloroplastic, and mitochondrial types, based on their subcellular localization. There is increasing evidence that AtNUDXs play physiological roles in the regulation of the levels of various metabolic intermediates and stress responses. Recently, we have reported that the regulation of intracellular levels of GDP-D-mannose, a metabolic intermediate of ascorbate biosynthesis, by cytosolic AtNUDX9 is involved in the response of plants to NH4+ and that the modulation of the cellular levels and redox state of pyridine nucleotides including NADPH by chloroplastic AtNUDX19 participates in the responses of plants to photooxidative stress and hormones. Furthermore, we have demonstrated that the regulation of cellular NADH levels by both cytosolic AtNUDX6 and 7 contributes to the modulation of the poly(ADP-ribosyl)ation reaction which is associated with the post-translational modi¿cation of proteins in biotic/abiotic stress responses, although the existence of AtNUDX6 and 7 themselves or other interacting factors is important for the control of salicylic acid signaling pathway. These findings suggest that NUDXs play important roles in various cellular responses through degradation of vitamin-derived coenzymes and their intermediates.
    Download PDF (1046K)
  • Yoshihisa Hirota
    2018 Volume 92 Issue 2 Pages 63-72
    Published: February 25, 2018
    Released on J-STAGE: February 28, 2019
    JOURNAL FREE ACCESS
    The vitamin K family comprises vitamin K1 (phylloquinone [PK]) derived from plants, vitamin K2 (menaquinone-n [MK-n]) from intestinal bacteria, and vitamin K3 (menadione [MD]) derived synthetically without a bioactive side chain. Diet-derived vitamin K mainly comprises PK but menaquinone-4 (MK4) is predominantly found in tissues. It has been predicted that PK undergoes a transformation to MK-4 in tissues, resulting in MK-4 accumulation within the tissues. However, the mechanism underlying this biotransformation has remained unknown for more than 60 years. Hence, we aimed to elucidate the mechanism underlaying the metabolic biotransformation of vitamin K.  Diet-derived vitamin K is partly absorbed by the lymphatic vessels in small intestinal villi, i.e., lacteals, and most of it is metabolized to MD by a side-chain cleavage enzyme in the small intestine, although this enzyme has been thought to be present in the tissue. The MD thus transformed from vitamin K is transported from the lymphatic vessels to all tissues via systemic circulation. We previously reported that MD is transformed to MK-4 by UbiA prenyltransferase domain containing protein 1 (UBIAD1) present in each tissue. The MK-4 thus transformed from MD acts as a biologically active vitamin K and exerts various physiological functions such as blood coagulation and bone formation via vitamin K-dependent gamma-carboxylase (GGCX), steroid and xenobiotic receptor (SXR), and protein kinase A (PKA) signaling. Therefore, we have proposed that MK-4 is no longer within a vitamin framework and that it has physiologically and nutritionally important hormone-like functions. Thus, we have successfully elucidated a part of the mechanism undelaying the metabolic biotransformation of vitamin K.
    Download PDF (1365K)
  • Application of determination method used for the vitamin D requirement
    Kiyoshi Tanaka, Misora Ao, Akiko Kuwabara
    2018 Volume 92 Issue 2 Pages 73-78
    Published: February 25, 2018
    Released on J-STAGE: February 28, 2019
    JOURNAL FREE ACCESS
    Vitamin deficiency causes classical deficiency diseases. Vitamin insufficiency is milder than vitamin deficiency but it increases the risk of non-communicable diseases (NCDs). Considering the importance of NCDs in Japan, vitamin requirement must be determined based on the risk reduction of NCDs. In Dietary Reference Intakes (DRIs) for Japanese 2015, vitamin B12requirement was determined based on the treatment outcome of anemia in patients with pernicious anemia, a vitamin B12deficiency disease, after intra-muscular injection of vitamin B12. However, there are various problems in this determination of vitamin B12requirement in DRIs for Japanese 2015. One of the problems is that the number of subjects is extremely small (N=7).
    Therefore, we attempted to propose a novel method to determine vitamin B12requirement based on the risk reduction of diseases. In the determination of vitamin B12requirement by this method, the risk of osteoporotic fracture due to vitamin D insufficiency was taNen into consideration. It was thought that vitamin D requirement determined by DRI in USA/Canada 2011 could be of use as a reference because the vitamin D requirement was determined by taking the risk of osteoporotic fracture due to vitamin D insufficiency into consideration. Vitamin B12or folate insufficiency causes hyperhomocysteinemia which is the risk factor of cardiovascular diseases and osteoporotic fracture. Our recent analysis of cohort studies led to the following findings: plasma homocysteine (Hcy) concentration made a good prediction for the risN of osteoporotic fracture and cardiovascular events. The cut-off value of plasma Hcy concentration to avoid such risks was less than 10 nmol/mL. This cut-off value of plasma Hcy concentration was lower than that cited in DRIs for Japanese 2015 (14 nmol/mL). To avoid this insufficiency, vitamin B12 requirement was much higher than that considered for a long time.
    In conclusion, we have proposed a novel method to determine vitamin B12requirement based on the risk reduction of diseases. The application of this method to the decision of DRIs in the future could be awaited.
    Download PDF (862K)
  • Hideyuki Hayashi
    2018 Volume 92 Issue 2 Pages 79-83
    Published: February 25, 2018
    Released on J-STAGE: February 28, 2019
    JOURNAL FREE ACCESS
    Download PDF (837K)
  • Fumio Watanabe
    2018 Volume 92 Issue 2 Pages 84-85
    Published: February 25, 2018
    Released on J-STAGE: February 28, 2019
    JOURNAL FREE ACCESS
    Download PDF (712K)
  • Tohru Yoshimura
    2018 Volume 92 Issue 2 Pages 86-89
    Published: February 25, 2018
    Released on J-STAGE: February 28, 2019
    JOURNAL FREE ACCESS
    Download PDF (754K)
  • Hideaki Tsuge
    2018 Volume 92 Issue 2 Pages 90
    Published: February 25, 2018
    Released on J-STAGE: February 28, 2019
    JOURNAL FREE ACCESS
    Download PDF (701K)
  • [in Japanese], [in Japanese], [in Japanese], [in Japanese], [in Japane ...
    2018 Volume 92 Issue 2 Pages 91-92
    Published: February 25, 2018
    Released on J-STAGE: February 28, 2019
    JOURNAL FREE ACCESS
    Download PDF (697K)
  • Hisaaki Mihara, [in Japanese], Yasushi Tani, [in Japanese], Ryuuta Tob ...
    2018 Volume 92 Issue 2 Pages 92
    Published: February 25, 2018
    Released on J-STAGE: February 28, 2019
    JOURNAL FREE ACCESS
    Download PDF (690K)
  • [in Japanese], Kiyoshi Fukui
    2018 Volume 92 Issue 2 Pages 93
    Published: February 25, 2018
    Released on J-STAGE: February 28, 2019
    JOURNAL FREE ACCESS
    Download PDF (649K)
  • [in Japanese]
    2018 Volume 92 Issue 2 Pages 94
    Published: February 25, 2018
    Released on J-STAGE: February 28, 2019
    JOURNAL FREE ACCESS
    Download PDF (648K)
  • Tatsuo Kurihara
    2018 Volume 92 Issue 2 Pages 94-95
    Published: February 25, 2018
    Released on J-STAGE: February 28, 2019
    JOURNAL FREE ACCESS
    Download PDF (655K)
  • Yoko Nitta
    2018 Volume 92 Issue 2 Pages 95-96
    Published: February 25, 2018
    Released on J-STAGE: February 28, 2019
    JOURNAL FREE ACCESS
    Download PDF (657K)
  • Katsushi Koyama
    2018 Volume 92 Issue 2 Pages 96-98
    Published: February 25, 2018
    Released on J-STAGE: February 28, 2019
    JOURNAL FREE ACCESS
    Download PDF (661K)
  • Nobuaki Wakamatsu, kenichiro Yamada, [in Japanese]
    2018 Volume 92 Issue 2 Pages 98
    Published: February 25, 2018
    Released on J-STAGE: February 28, 2019
    JOURNAL FREE ACCESS
    Download PDF (650K)
  • Kaduki Okamoto
    2018 Volume 92 Issue 2 Pages 99-100
    Published: February 25, 2018
    Released on J-STAGE: February 28, 2019
    JOURNAL FREE ACCESS
    Download PDF (736K)
  • Noe Kawade, [in Japanese], [in Japanese], Misato Kobayashi, Fumihiko H ...
    2018 Volume 92 Issue 2 Pages 101-102
    Published: February 25, 2018
    Released on J-STAGE: February 28, 2019
    JOURNAL FREE ACCESS
    Download PDF (706K)
  • Keisuke Sakiyama, Takahiro Ishikawa
    2018 Volume 92 Issue 2 Pages 102
    Published: February 25, 2018
    Released on J-STAGE: February 28, 2019
    JOURNAL FREE ACCESS
    Download PDF (649K)
  • Shosuke Kojo
    2018 Volume 92 Issue 2 Pages 102-103
    Published: February 25, 2018
    Released on J-STAGE: February 28, 2019
    JOURNAL FREE ACCESS
    Download PDF (656K)
  • 2018 Volume 92 Issue 2 Pages 104-108
    Published: February 25, 2018
    Released on J-STAGE: February 28, 2019
    JOURNAL FREE ACCESS
    Download PDF (803K)
feedback
Top